6A: PANEL: 51 Years of Buddy Ratner 2

Date: Friday, March 27, 2026
Time: 1:30 PM to 3:30 PM
Room: Centennial III/IV

Description

1:30 PM - 1:35 PM | Welcome

1:35 PM – 1:56 PM | Cole DeForest, University of Washington

1:56 PM – 2:17 PM | Stephanie Bryant, University of Colorado, Boulder

2:17 PM – 2:38 PM | Guillermo Ameer, Northwestern University

2:38 PM – 2:59 PM | Deborah Leckband, University of Illinois, Urbana-Champaign

2:59 PM – 3:20 PM | Michael Sefton, University of Toronto

3:20 PM – 3:30 PM | Buddy Ratner, University of Washington

Moderators:

Dr. Ashutosh Chilkoti
Distinguished Professor of Biomedical Engineering
Duke University

Gabriel Lopez
Distinguished Professor | Department of Chemical and Biological Engineering
The University of New Mexico

  • 1:35 PM. 279. Talk by Cole Deforest, University of Washington Speakers Prof. Cole DeForest
  • 1:56 PM. 280. Understanding and Controlling the Foreign Body Response Through Engineered Biomaterials. Stephanie Bryant, University of Colorado - Boulder Speakers Dr. Stephanie Bryant
  • 2:17 PM. 281. Talk by Guillermo Ameer, Northwestern University Speakers Guillermo Ameer
  • 2:38 PM. 282. Talk by Deborah Leckband, University of Illinois at Urbana - Champaign Speakers Deborah Leckband
  • 2:59 PM. 283. Rules Don't Make Art. Michael Sefton, University of Toronto Speakers Michael Sefton
  • 3:20 PM. 284. Talk by Buddy Ratner, Michael L. and Myrna Darland Endowed Chair in Technology Commercialization Professor of Bioengineering and Chemical Engineering, University of Washington Speakers Buddy Ratner

6B: Drug Delivery SIG 3: Next-Gen Nucleic Acid Delivery, Targeting, and Enabling Platforms

Date: Friday, March 27, 2026
Time: 1:30 PM to 3:30 PM
Room: Centennial I

Description

This session will survey the diverse range of contemporary drug delivery systems and innovations. Drug delivering biomaterials can include nanoparticles, hydrogels, nanofibers, cell and virus-derived particles, or bioconjugates. Payloads can include DNA, RNA, antibodies, recombinant proteins, or small molecules. Disease applications can range from neurodegeneration to autoimmune disease, trauma, infection, or cancer. Work at all scales, from basic formulation science through therapeutic application in disease models is welcome. Studies that critically evaluate the impact of injection route on treatment efficacy and/or use novel imaging modalities to evaluate drug delivery performance are especially encouraged.

Moderators:

Dhanashree Hemant Surve
University of Miami

Laura Bracaglia, Ph.D
Assistant Professor
Villanova University

John Clegg
Assistant Professor
Gallogly College of Engineering
Peggy and Charles Stephenson School of Biomedical Engineering
The University of Oklahoma

  • 1:30 PM. 285. Error-free high-throughput screening of LNP in vivo via sequencing of tissue.Atip Lawanprasert, Ph.D.1, York Tang1, Manon Miller2, Yifan Chang, MD2, Jaidev Bapat, Ph.D.2, Rohit Sharma, Ph.D.1, Dengpan Liang, Ph.D.1, Katherine Fuh, MD, Ph.D.2, Niren Murthy, Ph.D.1 1University of California, Berkeley, 2University of California, San Francisco
  • 1:45 PM. 286. Engineering placenta-tropic lipid nanoparticles to treat pregnancy disorders.Kelsey Swingle, Ph.D.1 1Rice University
  • 2:00 PM. 287. Airway delivery of circRNA using pulmonary-surfactant-coated lipid nanoparticles for cystic fibrosis gene therapy.Guizhi Zhu, PhD1 1University of Michigan
  • 2:15 PM. 288. Analysis of Light-Induced Degradation of Curcumin in UV-Crosslinkable PVA Microneedle Systems.Yeong Min Kang1, Min Hee Kim2, Won Ho Park1 1Chungnam National University, 2Kyungpook National University
  • 2:30 PM. 289. Development of Poly(ethylene) glycol hydrogel drug delivery device to study intramuscular adipose tissue signaling.Rebekah Boos, BS1, Chang Gui, PhD2, Gretchen Meyer, PhD2, Silviya Zustiak, PhD1 1Saint Louis University, 2Washington University in St. Louis
  • 2:45 PM. 290. Ultrasound-responsive dendrimers for targeted cancer gene therapy.Nikita Sehgal, MS1, Kevin Schilling, PhD1, Carolyn Schutt Ibsen, PhD2, Jason Ware, PhD1, Sean Hamilton, PhD1 1Oregon Health& Science University, 2Oregon Health and Science University
  • 3:00 PM. 291. Modernizing Biolistic Delivery for High-Efficiency Delivery of DNA, Proteins, and CRISPR/Cas Editing Tools.Shan Jiang1 1Iowa State Unviersity
  • 3:15 PM. 292. Optimizing Polymer Nanoparticle-Mediated Nucleic Acid Delivery and Endosomal Escape for Inhibition of Endothelial Inflammation.Valerie Lallo, MS1, Laura Bracaglia, PhD1 1Villanova University

6C: Biomaterials for ImmunoEngineering 2

Date: Friday, March 27, 2026
Time: 1:30 PM to 3:30 PM

Description

Over the past decade the focus of many bioengineers and clinicians has been shifting towards "immune engineering" approaches that include but are not limited to engineered biomaterials for vaccines, immunotherapy (immune modulation), cell and gene therapy, immune microenvironment engineering, and systems immunology. These research areas embrace a comprehensive list of translational immunology-associated problems including chronic infections, autoimmune diseases, aggressive cancers, allergies, etc. The purpose of the Immune Engineering SIG is to bring together emerging ideas and provide a venue for professional interaction to a large number of academic and industrial research groups and scientists working in these areas.

  • 1:30 PM. 293. Biomaterial Assisted Lung-Lymphatic Assembly Recapitulates Influenza Infection.Eshant Bhatia, PhD1, Rachel Ringquist, Ph.D1, Krishnendu Roy, Ph.D.2, Ankur Singh, Dr.1 1Georgia Institute of Technology, 2Vanderbilt University
  • 1:45 PM. 294. Defining the Epigenetic Landscape of Tonsil and PBMC-derived Synthetic Human Immune Organoids.Ishita Jain, PhD1, Andrés García, PhD2, Ankur Singh, Dr.2, Zhe Zhong2, Christopher Scharer, Dr.2 1Stanford University, 2Georgia Institute of Technology
  • 2:00 PM. 295. Adjuvanted Nanomaterials Reveal the Influence of Dendritic Cell Tissue Residency on Antitumor Immunity.Samuel Lucas1, Alexander Heiler1, Guanzhen He1, Margaret Manspeaker, Ph.D.1, Susan Thomas, Ph.D.1 1Georgia Institute of Technology
  • 2:15 PM. 296. Local Delivery of Anti-Cytokine Active Immunotherapy to Treat Pulmonary Fibrosis.Maria Kulapurathazhe1, Shamitha Shetty1, Pablo Cordero1, Joel Collier, PhD1 1Duke University
  • 2:30 PM. 297. Nanoparticles Induce Differentiation of Monocytes into Antigen-Presenting Monocyte-Derived Dendritic Cells in Murine Triple Negative Breast Cancer.Kate Griffin, BS, MS1, Jeffrey Ma, BS, PhD1, Kathryn Kang, BS, MS1, Agustina Diener, BS1, Rebecca Pereles, BS, MS1, Jacqueline Jeruss, MD, PhD1, Lonnie Shea2 1University of Michigan- Ann Arbor, 2University of Michigan
  • 2:45 PM. 298. A Heparin-containing Hydrogel System for Localized and Sustained Release of IL-10 for Rotator Cuff Injuries.Jiahui Mao, B.S., M.S.1, Johnna Temenoff2 1Georgia Institute of Technology & Emory University, 2Georgia Institute of Technology
  • 3:00 PM. 299. An oxygenated biohybrid device for the long-term delivery of checkpoint and cytokine therapies.Jake Schladenhauffen1, Cody Fell1, Anthony Davis1, Grace May1, Shalini Pandey, PhD1, Abhijith Surendran, PhD2, Inkyu Lee3, Peter Rios, PhD4, Daisy Lopez4, José Oberholzer, MD4, Tzahi Cohen-Karni, PhD3, Jonathan Rivnay, PhD2, Omid Veiseh, PhD1 1Rice University, 2Northwestern University, 3Carnegie Mellon University, 4CellTrans, Inc
  • 3:15 PM. 300. Examining the role of aging and biological sex on lymph node biomechanics.Vedanth Sriram, B.S., M.S.1, Katharina Maisel, PhD2, Rebecca Lu1, Adedamola owolabi1, Calvin Witt1 1University of Maryland, College Park, 2University of Maryland

6D: Sex, Age, and Equity as Biological Variables in Biomaterials Research

Date: Friday, March 27, 2026
Time: 1:30 PM to 3:30 PM
Room: Hanover AB

Description

This session will cover recent advances in biomaterials research and engineering innovations aimed at improving women’s health, including maternal health, reproductive technologies, gynecologic conditions, and cancers such as breast, cervical, and ovarian cancer. Speakers will present biomaterials-based approaches in drug delivery, implantable devices, diagnostics, and tissue engineering that address clinical needs unique to women. We will also emphasize sex and age as important biological variables in biomaterials research, and include emerging technologies to understand immune responses, disease mechanisms, and therapeutic outcomes. In addition,
this session will incorporate principles of health equity and biomaterials-based solutions to address health disparities.

  • 1:30 PM. 301. Modulating acute innate immune cell infiltration to the injured brain following TBI.Amberlyn Simmons, B.S.1, Sierra Chimene, MS1, Diana Herrera-Diaz1, Crystal Willingham, M.S.1, Amanda Witten, B.S.1, Heather Bimonte-Nelson, PhD1, Chris Plaisier, PhD1, Rachael Sirianni, PhD2, Sarah Stabenfeldt, PhD1 1Arizona State University, 2UMass Chan Medical School
  • 1:45 PM. 302. Placental cell type influence on mRNA loaded lipid nanoparticle delivery and gene expression.Alexandra Harrison1, Adelyn Fisher1, Elizaveta Tcherniaeva1, Christina Bailey-Hytholt, PhD1 1Worcester Polytechnic Institute
  • 2:00 PM. 303. Development a Bioengineered Ovarian Implant for Physiological Hormone Restoration.Alexander Noblett1, Ferran Barrachina1, Bruna Paulsen1, Brian Pham1, Mark Johnson1, Pia Martindale1, Niloofar Motahari1, Vaishnavi Venkat1, Christian Kramme1 1Gameto
  • 2:15 PM. 304. Dose-Dependent Effects of Extracellular Matrix Motifs Promote Bone Regeneration in Females.Victoria Garza, BS1, Opemipo Sanyaolu, BS2, Rena Bizios3, Gabriela Cervantes-Gonzales3, Teja Guda3, Alisa Isaac, PhD4 1UT San Antonio, 2University of the Incarnate Word, 3The University of Texas at San Antonio, 4St. Mary's University
  • 2:30 PM. 305. Biodegradable Implant-Mediated Sustained Aromatase Inhibitor Delivery for Endometriosis Therapy.Lisha Awasthi1, Rohit Srivastava, Prof.1, Jayesh Bellare1 1Indian Institute of Technology Bombay
  • 2:45 PM. 306. Sex-Specific Biomaterials Preserve Differences in Human Idiopathic Pulmonary Fibrosis Microenvironments.Haley Noelle, BS1, Mikala Mueller, BS, MS1, Rachel Blomberg, BS, PhD1, Nicole Sempertegui Plaza, BS, PhD1, Brisa Peña, BS, MS, PhD1, Chelsea Magin, BS, PhD1 1University of Colorado Denver | Anschutz
  • 3:00 PM. 307. Minimally-Invasive Hemostatic Hydrogel with Tissue Adhesion for Postpartum Hemorrhage.Sarah Miller1, Anya Stolyarova1, Prasenjeet Ingole1, Ryan Davis Jr.1, Akhilesh Gaharwar1 1Texas A&M University
  • 3:15 PM. 308. Bioengineered 3D Myometrium as a Functional Platform to Model Human Uterine Contractility.Karla Ortega Sandoval1, Ritu Dave2, Shreya Artha Raghavan, Associate Professor3, Antonina Frolova, Assistant Professor, Obstetrics and Gynecology Division of Maternal-Fetal Medicine2, Kaci Mitchum2, Alana Aristimuno Millan1 1Texas A&M, 2Washington University in St. Louis, 3texas a&m university

6E: Granular & Macroporous Biomaterials for Tissue Engineering 1

Date: Friday, March 27, 2026
Time: 1:30 PM to 3:30 PM
Room: Hanover CDE

Description

Granular hydrogel materials emerged as a class of biomaterial that provide for well-defined in vitro and in vivo systems with plug-and-play components and tissue-mimicking 3D environments. Granular hydrogels are composed of a slurry of microgel particles that are assembled to form a larger porous structure. Microporous annealed particle (MAP) scaffolds are a subclass of granular hydrogel material with a void space network stabilized by inter-particle chemical bonds. The modular nature of granular hydrogels offers enormous tunability in not only the individual microgel design but also the homogenous or heterogenous microgel assembly into the bulk scaffold. This session will explore current advances in granular hydrogel technology, including MAP scaffolds, for both immune modulation, tissue repair, organ-on-a-chip, and 3D-printing applications.

Moderators:

Tatiana Segura
Duke University

Donald Griffin
The University of Virginia

  • 1:30 PM. 309. Engineering Dynamics and Porosity in Granular Biomaterials Using Fiber Particles for Regenerative Medicine and Multicellular Assembly. Chris Highley, Ph.D, University of Virginia Speakers Dr. Chris Highley
  • 2:00 PM. 310. Affibody-Conjugated Hydrogel Microparticles for Affinity-Controlled Delivery of Angiogenic Proteins.Juan Garcia, BS1, Marian Hettiaratchi, Ph.D.2 1University of Oregon, 2University of Oregon Knight Campus
  • 2:15 PM. 311. Varying Peptide Linkers to Modulate Degradation of Microporous Annealed Particle Scaffolds for Diabetic Wounds.Claudia Daboin1, Don Griffin, Ph.D.1 1University of Virginia
  • 2:30 PM. 312. Modular control of hydrolytic degradation in microporous granular hydrogels guides skeletal muscle repair.Taimoor Qazi1, Zhiyuan Chen1, Tuba Marjan1, Nicole Mertens1 1Purdue University
  • 2:45 PM. 313. Photo-Responsive Granular Hydrogels for Spatiotemporal Control of Material Properties and Cell Phenotype.Nicole Friend, PhD1, Mark Young, PhD1, Kara Shockley1, Daniel Saeb1, Kristi Anseth2 1University of Colorado, Boulder, 2University of Colorado at Boulder
  • 3:00 PM. 314. Distinct Degradation Rates of MAP-AC and MAP-VS Hydrogels Modulate Healing Trajectories in Cutaneous Regeneration.Alejandra Suarez-Arnedo1, Amy Kim1, Tatiana Segura, PhD1 1Duke University
  • 3:15 PM. 315. High-throughput buoyancy-clearing microgel production for simple user interfacing.Durante Pioche-Lee1, Sasha Cai Lesher-Pérez2 1Univeristy of Michigan, 2University of Michigan-- Ann Arbor

6F: Manufacturing and Translation of Polymer-Based Implants, Fibrous Interfaces, and Tissue Engineering Scaffolds

Date: Friday, March 27, 2026
Time: 1:30 PM to 3:30 PM
Room: Hanover FG
  • 1:30 PM. 316. Developing Matrix Protein-Decorated Microporous Annealed Particle Scaffolds for Accelerated Scaffold Integration.Ethan Nicklow1, Don Griffin, Ph.D.1, James Daniero1 1University of Virginia
  • 1:45 PM. 317. Bidirectional collagen fiber alignment through extrusion-based 3D printing for cell orientation.Diya Singhal1, Fotis Christakopoulos, PhD1, Lucia Brunel, PhD1, David Myung, PhD1, Gerald Fuller, PhD1, Sarah Heilshorn, PhD1 1Stanford University
  • 2:00 PM. 318. Clinical Translation and Long-Term Efficacy of a Synthetic Electrospun Fiber Matrix for Soft Tissue Healing.Matthew MacEwan, PhD1, KC Donaldson, MS1, Emily Sallade, MS1 1Acera Surgical, Inc.
  • 2:15 PM. 319. Synthesis and Characterization of Poly (Glycerol Dodacanedioate) Methacrylate as a Photocrosslinkable Shape Memory Biomaterial.Moontaha Farin1 1The University of Akron
  • 2:30 PM. 320. Novel Fabrication of PEEK Using Fused Strand Deposition Reduces Inflammatory Cytokines and Enhances MSC Differentiation in Vitro, Promoting Bone Growth and Implant Osseointegration Clinically.Jonathan Dillon, Bachelor of Science1, David Cohen, MD1, Jingyao Deng, Bachelor of Science1, Todd Reith2, Ellie Sabalewski1, Dmitry Pestov, PhD1, Ammar Jawad1, Paul Slosar, MD3, Kevin Foley, MD4, Randall Dryer, MD5, Timothy Bassett, MD6, Chambliss Harrod, MD7, Brian Verrelli, PhD1, Massimo Bertino, PhD1, Erik Erbe, PhD2, Zvi Schwartz, PhD, DMD1, Barbara Boyan, PhD1 1Virginia Commonwealth University, 2Curiteva, Inc., 3Peninsula Orthopedic Associates, 4Semmes-Murphy Neurologic and Spine Institute, 5Central Texas Spine Institute, 6Southeastern Spine Specialists, 7The Spine Center of Louisiana
  • 2:45 PM. 321. Touch-Spinning of Manuka Honey-Incorporated Immunomodulatory Tissue-Engineering Vascular Grafts.Evan Main, M.S.1, Alexandra Snyder1, Audrey Alberson1, Jada Sandridge1, Gary Bowlin, Ph.D.1 1The University of Memphis
  • 3:00 PM. 322. Engineering a Volumetrically-Printed, Osteoconductive Bone Allograft Delivery System.Julia Andraca Harrer, BS, MS, PhD1, Patrick Hall2, Maya Kasteleiner2, Strata Kim, B.S1, Kait Link, DVM1, Gabriella Lindberg, PhD2, Paul Dalton, PhD1, Nick Willett, PhD1 1University of Oregon, 2Knight Campus, University of Oregon
  • 3:15 PM. 323. Engineering New Forms of Electrospun Nanofiber Materials for Biomedical Applications.Jingwei Xie1 1University of Nebraska Medical Center

6G: Nanomaterials SIG: Nanomaterials in Health and Disease

Date: Friday, March 27, 2026
Time: 1:30 PM to 3:30 PM
Room: GH East AB

Description

This session is intended to focus on mechanistic aspects of nanomaterial development leading to their application for treatment or diagnoses of disease. We encourage submissions that make the connection between mechanistic observations (such as nanomaterial surface characteristics, formulation approaches, or mode of interaction with cells and tissues) and the outcomes of such systems in vivo. This may include work on targeted delivery, biosensors, therapeutics, imaging agents, or others. The underlying theme for this session focuses on the principal that better understanding of mechanism leads to better material engineering. We welcome abstract submission from all scientific levels (trainee to faculty) and encourage topics that address diseases and topics that are otherwise understudied.

Moderators:
Kelly Langert, Ph.D
Loyola University Chicago

Ester Kwon, Ph.D
Assistant Professor, Bioengineering
Sanford Consortium for Regenerative Medicine

  • 1:30 PM. 324. Polycatecholic Nanoparticles to Restore Macrophage Homeostasis in Aged Microenvironments.Cameron Moore, M.S.1, Danielle Benoit1 1University of Oregon
  • 1:45 PM. 325. Combining Enzymes and Oxygen-Responsive Phosphorescent Nanoparticles to Engineering a Chemo-Optical Phosphate Biosensor for Hyperphosphatemia Management.Su Jeong Ahn, MS 1, Daniel Alge, PhD 1, Michael McShane, PhD 1 1Texas A&M University
  • 2:00 PM. 326. Unraveling Nanospiral Morphology Mechanism in Self-Assembling Peptide Hydrogels.Paul Eisold1, Jonathan Florian, B.S.1, Diana Kirilov2, Justin Kim3, Kyle Lampe, PhD1 1University of Virginia, 2Merck, 3University of Florida
  • 2:15 PM. 327. Protein Corona Profiling: Bridging Silk Nanoparticle Surface Chemistry and Cellular Uptake Dynamics.Charlotte Jacobus1, Sawnaz Shaidani2, Mynaja Ferguson3, Hom Rijal3, Shawn Cui1, Rachel Muriph3, Jason Evans3, David Kaplan1 1Tufts University, 2Werfen, 3University of Massachusetts Boston
  • 2:30 PM. 328. Optimization of Novel Ultrasonic Shearing Manufacturing Method for Nanobubble Manufacturing.Margaret Nanfria, BSc1, Sun Latt1, Pedram Sotoudehbagha, PhD1, Andres Alayon Mata1, Elayaraja Kolanthai, PhD2, Abhijith Rangavajjula2, Sudipta Seal, PhD2, Melanie Coathup, PhD1, Mehdi Razavi, PhD1 1University of Central Florida, College of Medicine, 2University of Central Florida
  • 2:45 PM. 329. Engineering protein-based nanoparticle stability through tunable hysteretic phase separation behaviors.Alexa Regina Avecilla1, Felipe Quiroz, PhD1 1Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University
  • 3:00 PM. 330. Charge switching lipid nanoparticles are non-immunogenic and deliver mRNA efficiently.Dengpan Liang, Ph.D.1, Hesong Han, Ph.D.1, Yalin Qi, Ph.D.1, Atip Lawanprasert, Ph.D.1, Kaycee Sapasap, B.S.1, Yuxi Zhang, B.S.1, Silin Guo, B.S.1, Milan Del Buono, B.S.1, Benjamin Burgstone, B.S.1, Neel Dankar, B.S.1, Sheng Zhao, Ph.D.1, Niren Murthy, Ph.D.1 1University of California, Berkeley
  • 3:15 PM. 331. Volatile-barcoded probes for multiplexed protease activity sensing for chronic lung allograft dysfunction diagnosis.Khoi Le, BS1, Patrick McLinden, BS2, Ragini Vittal, PhD2, Vishal Manickam, BS1, Thomas Li, BS1, Morgan Summerlin1, Peng Qiu, PhD1, Vibha Lama, MD2, Leslie Chan, PhD1 1Georgia Institute of Technology, 2Emory University

6H: Surface Characterization and Modification & Gasotransmitter

Date: Friday, March 27, 2026
Time: 1:30 PM to 3:30 PM
Room: GH East CD

Description

This session will explore cutting-edge strategies for surface characterization and modification to improve biomaterial performance in complex physiological environments. Talks will highlight emerging analytical techniques, engineered interfaces, and functional coatings that modulate cellular interactions and improve device integration. This session will also feature innovations in gasotransmitter-releasing biomaterials – such as nitric oxide, designed to enhance the infection resistance and hemocompatibility of devices.

Moderators:

Elizabeth Brisbois, Ph.D
Principal Investigator
University of Georgia

Mark Garren, Ph.D
Clinical Assistant Professor
University of Gerogia | College of Engineering

Lichong Xu, Ph.D
Associate Professor, Surgery
Penn State College of Medicine

  • 1:30 PM. 332. Photo-Carbon Monoxide Releasing Molecules to Reduce Biofilms in Vascular Grafts.Chris Bashur, PhD1, Sunita George, MS1, Beste Caner, MS1, Anjali Kannan1, Yi Liao, PhD1 1Florida Institute of Technology
  • 1:45 PM. 333. Carbon monoxide-entrapping materials for immunomodulation.Jianling Bi, PhD1, Emily Witt, MS2, Arielle Cafi, BS2, Kyle Balk, BS2, James Byrne, MD, PhD2 1Women and Children's Hospital of Chongqing Medical University, 2University of Iowa
  • 2:00 PM. 334. Development of Anti-biofouling Organogel with Continuous Lubricating Network.Myddelton Parker1, Arpita Shome, Ph.D.1, Vicente Pinon1, Natalie Crutchfield1, Mark Garren, Ph.D.1, Elizabeth Brisbois, Ph.D.1, Hitesh Handa, Ph.D.1 1University of Georgia
  • 2:15 PM. 335. Tunable Surface Characteristics on Poly-(Amine-co-Ester) (PACE) Polymeric Nanoparticles and the Effect on Endothelial Cellular Drug Delivery.Jianlei Wu, Master of Science1, Laura Bracaglia, PhD1 1Villanova University
  • 2:30 PM. 336. Long-Term Nitric Oxide-Releasing Aliphatic Lubricants: Infusion in Polymers for Enhanced Slippery and Antibacterial Efficacy.Grace Nguyen1, Mark Garren, Ph.D.1, McKenna Clary1, Vicente Pinon1, Hitesh Handa, Ph.D.1, Elizabeth Brisbois, Ph.D.1 1University of Georgia
  • 2:45 PM. 337. Sensitive nitric oxide detection via diamino-rhodamine B loaded microneedles.Zheng-Chi Lee1, Leo Wang, MD, PhD, FAAD2 1Perelman School of Medicine, University of Pennsylvania, 2University of Pennsylvania
  • 3:00 PM. 338. Scanning Impedance Microscopy - A New Electrochemically-Based Imaging Method for Metallic Biomaterials Surfaces: Electrocautery-Induced Damage.Dinghe Liu, M.S.1, Mohsen Karshenas, M.S.1, Amandine Impergre, Ph.D.1, Jeremy Gilbert, Ph.D.1 1Clemson University
  • 3:15 PM. 339. Integration of Drug-Loaded Manganese Dioxide Nanoparticles on Nitric Oxide-Releasing Polymers for Broad-Spectrum Antimicrobial Medical Device Surfaces.Vicente Pinon1, Sumit Kumar, Ph.D.1, Natalie Crutchfield1, Aasma Sapkota1, Tia Shorter1, Elizabeth Brisbois, Ph.D.1, Hitesh Handa, Ph.D.1 1University of Georgia